PL100077B1 - Sposob wytwarzania nowych pochodnych imidazoizochinoliny - Google Patents
Sposob wytwarzania nowych pochodnych imidazoizochinoliny Download PDFInfo
- Publication number
- PL100077B1 PL100077B1 PL18494675A PL18494675A PL100077B1 PL 100077 B1 PL100077 B1 PL 100077B1 PL 18494675 A PL18494675 A PL 18494675A PL 18494675 A PL18494675 A PL 18494675A PL 100077 B1 PL100077 B1 PL 100077B1
- Authority
- PL
- Poland
- Prior art keywords
- isoquinoline
- imidazo
- compounds
- formula
- compound
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 47
- -1 methoxy, ethoxy, propoxy, isopropoxy, isobutoxy, tertiary butoxy, pentyloxy, isoamyloxy, 2-methylbutoxy Chemical group 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 15
- 238000002513 implantation Methods 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052801 chlorine Inorganic materials 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 4
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- GQSHFYGCUBUDCI-UHFFFAOYSA-N 3h-imidazo[4,5-h]isoquinoline Chemical class C1=CN=CC2=C(NC=N3)C3=CC=C21 GQSHFYGCUBUDCI-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 230000035558 fertility Effects 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims 20
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 claims 17
- 230000035935 pregnancy Effects 0.000 claims 16
- 210000003754 fetus Anatomy 0.000 claims 9
- 239000000243 solution Substances 0.000 claims 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 6
- 210000000582 semen Anatomy 0.000 claims 6
- 238000012360 testing method Methods 0.000 claims 6
- 210000004291 uterus Anatomy 0.000 claims 5
- PENWAFASUFITRC-UHFFFAOYSA-N 2-(4-chlorophenyl)imidazo[2,1-a]isoquinoline Chemical compound C1=CC(Cl)=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 PENWAFASUFITRC-UHFFFAOYSA-N 0.000 claims 4
- 241000700159 Rattus Species 0.000 claims 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 4
- 239000002585 base Substances 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 238000005984 hydrogenation reaction Methods 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 4
- 239000000376 reactant Substances 0.000 claims 4
- 238000005303 weighing Methods 0.000 claims 4
- ZYWYGWRRHDDHSN-UHFFFAOYSA-N 2-(4-methoxyphenyl)imidazo[2,1-a]isoquinoline Chemical compound C1=CC(OC)=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 ZYWYGWRRHDDHSN-UHFFFAOYSA-N 0.000 claims 3
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 3
- 241000699800 Cricetinae Species 0.000 claims 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 125000003302 alkenyloxy group Chemical group 0.000 claims 3
- 239000000908 ammonium hydroxide Substances 0.000 claims 3
- 239000003054 catalyst Substances 0.000 claims 3
- 230000001605 fetal effect Effects 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- OSILBMSORKFRTB-UHFFFAOYSA-N isoquinolin-1-amine Chemical compound C1=CC=C2C(N)=NC=CC2=C1 OSILBMSORKFRTB-UHFFFAOYSA-N 0.000 claims 3
- 239000003960 organic solvent Substances 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 239000008159 sesame oil Substances 0.000 claims 3
- 235000011803 sesame oil Nutrition 0.000 claims 3
- 210000001215 vagina Anatomy 0.000 claims 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 2
- DXQRYFLJALBVOM-UHFFFAOYSA-N 2-(2-chlorophenyl)imidazo[2,1-a]isoquinoline Chemical compound ClC1=CC=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 DXQRYFLJALBVOM-UHFFFAOYSA-N 0.000 claims 2
- JNJGNJXCTIUHCW-UHFFFAOYSA-N 2-(2-methoxyphenyl)imidazo[2,1-a]isoquinoline Chemical compound COC1=CC=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 JNJGNJXCTIUHCW-UHFFFAOYSA-N 0.000 claims 2
- FRCIBYDYVXQXGC-UHFFFAOYSA-N 2-(3-chlorophenyl)imidazo[2,1-a]isoquinoline Chemical compound ClC1=CC=CC(C=2N=C3C4=CC=CC=C4C=CN3C=2)=C1 FRCIBYDYVXQXGC-UHFFFAOYSA-N 0.000 claims 2
- MXJCXFPPJMNAMP-UHFFFAOYSA-N 2-(3-ethoxyphenyl)imidazo[2,1-a]isoquinoline Chemical compound CCOC1=CC=CC(C=2N=C3C4=CC=CC=C4C=CN3C=2)=C1 MXJCXFPPJMNAMP-UHFFFAOYSA-N 0.000 claims 2
- BHVYXFROIATQQJ-UHFFFAOYSA-N 2-(3-methoxyphenyl)imidazo[2,1-a]isoquinoline Chemical compound COC1=CC=CC(C=2N=C3C4=CC=CC=C4C=CN3C=2)=C1 BHVYXFROIATQQJ-UHFFFAOYSA-N 0.000 claims 2
- HQXUZQPZCUBNCQ-UHFFFAOYSA-N 2-(3-propoxyphenyl)imidazo[2,1-a]isoquinoline Chemical compound CCCOC1=CC=CC(C=2N=C3C4=CC=CC=C4C=CN3C=2)=C1 HQXUZQPZCUBNCQ-UHFFFAOYSA-N 0.000 claims 2
- RIWBAVICDRBVGP-UHFFFAOYSA-N 2-(4-bromophenyl)imidazo[2,1-a]isoquinoline Chemical compound C1=CC(Br)=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 RIWBAVICDRBVGP-UHFFFAOYSA-N 0.000 claims 2
- NROCNRLEWWJNJK-UHFFFAOYSA-N 2-(4-fluorophenyl)imidazo[2,1-a]isoquinoline Chemical compound C1=CC(F)=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 NROCNRLEWWJNJK-UHFFFAOYSA-N 0.000 claims 2
- LKENZGMGOAVEHZ-UHFFFAOYSA-N 2-phenylimidazo[2,1-a]isoquinoline Chemical compound N1=C2C3=CC=CC=C3C=CN2C=C1C1=CC=CC=C1 LKENZGMGOAVEHZ-UHFFFAOYSA-N 0.000 claims 2
- 206010000234 Abortion spontaneous Diseases 0.000 claims 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 208000009628 Fetal Resorption Diseases 0.000 claims 2
- 208000032843 Hemorrhage Diseases 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 241000699673 Mesocricetus auratus Species 0.000 claims 2
- 238000011887 Necropsy Methods 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- 230000005856 abnormality Effects 0.000 claims 2
- 230000003509 anti-fertility effect Effects 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 2
- 230000004071 biological effect Effects 0.000 claims 2
- 238000009835 boiling Methods 0.000 claims 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 238000002224 dissection Methods 0.000 claims 2
- 238000002474 experimental method Methods 0.000 claims 2
- 239000012458 free base Substances 0.000 claims 2
- 230000003054 hormonal effect Effects 0.000 claims 2
- 229930195733 hydrocarbon Natural products 0.000 claims 2
- 150000002430 hydrocarbons Chemical class 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 239000003701 inert diluent Substances 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 230000013011 mating Effects 0.000 claims 2
- 231100000324 minimal toxicity Toxicity 0.000 claims 2
- 208000015994 miscarriage Diseases 0.000 claims 2
- 230000003169 placental effect Effects 0.000 claims 2
- 238000011160 research Methods 0.000 claims 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 2
- 235000011152 sodium sulphate Nutrition 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 208000000995 spontaneous abortion Diseases 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 239000000375 suspending agent Substances 0.000 claims 2
- 239000006188 syrup Substances 0.000 claims 2
- 235000020357 syrup Nutrition 0.000 claims 2
- 239000000454 talc Substances 0.000 claims 2
- 229910052623 talc Inorganic materials 0.000 claims 2
- 235000012222 talc Nutrition 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- 239000000080 wetting agent Substances 0.000 claims 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 claims 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 1
- ZYRGNHUFLIHWRW-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-5,6-dihydroimidazo[2,1-a]isoquinoline Chemical compound C1=CC=C2C3=NC(C4=CC=C5OCOC5=C4)=CN3CCC2=C1 ZYRGNHUFLIHWRW-UHFFFAOYSA-N 0.000 claims 1
- VQAYAWVYSTZIDC-UHFFFAOYSA-N 2-(2,5-dimethoxyphenyl)-5,6-dihydroimidazo[2,1-a]isoquinoline Chemical compound COC1=CC=C(OC)C(C=2N=C3C4=CC=CC=C4CCN3C=2)=C1 VQAYAWVYSTZIDC-UHFFFAOYSA-N 0.000 claims 1
- SMLOKZNNPBZYEO-UHFFFAOYSA-N 2-(2,5-dimethoxyphenyl)imidazo[2,1-a]isoquinoline Chemical compound COC1=CC=C(OC)C(C=2N=C3C4=CC=CC=C4C=CN3C=2)=C1 SMLOKZNNPBZYEO-UHFFFAOYSA-N 0.000 claims 1
- JRYSEMBSKLGWGA-UHFFFAOYSA-N 2-(2-methoxyphenyl)-5,6-dihydroimidazo[2,1-a]isoquinoline Chemical compound COC1=CC=CC=C1C1=CN(CCC=2C3=CC=CC=2)C3=N1 JRYSEMBSKLGWGA-UHFFFAOYSA-N 0.000 claims 1
- BTWRXDIOLRSILN-UHFFFAOYSA-N 2-(3,4-dibromophenyl)imidazo[2,1-a]isoquinoline Chemical compound C1=C(Br)C(Br)=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 BTWRXDIOLRSILN-UHFFFAOYSA-N 0.000 claims 1
- DVLKIVMSPQCCLW-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)imidazo[2,1-a]isoquinoline Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 DVLKIVMSPQCCLW-UHFFFAOYSA-N 0.000 claims 1
- CNZQZPPXINFGBR-UHFFFAOYSA-N 2-(3-ethoxyphenyl)-5,6-dihydroimidazo[2,1-a]isoquinoline Chemical compound CCOC1=CC=CC(C=2N=C3C4=CC=CC=C4CCN3C=2)=C1 CNZQZPPXINFGBR-UHFFFAOYSA-N 0.000 claims 1
- UFHLCDBAGJEMTD-UHFFFAOYSA-N 2-(3-fluorophenyl)imidazo[2,1-a]isoquinoline Chemical compound FC1=CC=CC(C=2N=C3C4=CC=CC=C4C=CN3C=2)=C1 UFHLCDBAGJEMTD-UHFFFAOYSA-N 0.000 claims 1
- VCMJVKCVBRDWNI-UHFFFAOYSA-N 2-(3-methoxyphenyl)-5,6-dihydroimidazo[2,1-a]isoquinoline Chemical compound COC1=CC=CC(C=2N=C3C4=CC=CC=C4CCN3C=2)=C1 VCMJVKCVBRDWNI-UHFFFAOYSA-N 0.000 claims 1
- TWKZTFKWSQOEQB-UHFFFAOYSA-N 2-(3-pentoxyphenyl)imidazo[2,1-a]isoquinoline Chemical compound CCCCCOC1=CC=CC(C=2N=C3C4=CC=CC=C4C=CN3C=2)=C1 TWKZTFKWSQOEQB-UHFFFAOYSA-N 0.000 claims 1
- ZHOVVTLZEFCCSV-UHFFFAOYSA-N 2-(3-prop-2-enoxyphenyl)imidazo[2,1-a]isoquinoline Chemical compound C=CCOC1=CC=CC(C=2N=C3C4=CC=CC=C4C=CN3C=2)=C1 ZHOVVTLZEFCCSV-UHFFFAOYSA-N 0.000 claims 1
- ZESKDRFRGPLAFI-UHFFFAOYSA-N 2-(3-propoxyphenyl)-5,6-dihydroimidazo[2,1-a]isoquinoline Chemical compound CCCOC1=CC=CC(C=2N=C3C4=CC=CC=C4CCN3C=2)=C1 ZESKDRFRGPLAFI-UHFFFAOYSA-N 0.000 claims 1
- ULIPBTVLEIOHFO-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-methylimidazo[2,1-a]isoquinoline Chemical compound N1=C2C3=CC=CC=C3C=CN2C(C)=C1C1=CC=C(Cl)C=C1 ULIPBTVLEIOHFO-UHFFFAOYSA-N 0.000 claims 1
- XBPOJSQQHMGAHQ-UHFFFAOYSA-N 2-(4-methoxyphenyl)-5,6-dihydroimidazo[2,1-a]isoquinoline Chemical compound C1=CC(OC)=CC=C1C1=CN(CCC=2C3=CC=CC=2)C3=N1 XBPOJSQQHMGAHQ-UHFFFAOYSA-N 0.000 claims 1
- FBVFNDQSUFGKAL-UHFFFAOYSA-N 2-(4-methylphenyl)imidazo[2,1-a]isoquinoline Chemical compound C1=CC(C)=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 FBVFNDQSUFGKAL-UHFFFAOYSA-N 0.000 claims 1
- GJSSHAICDVKMOW-UHFFFAOYSA-N 2-(4-nitrophenyl)imidazo[2,1-a]isoquinoline Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 GJSSHAICDVKMOW-UHFFFAOYSA-N 0.000 claims 1
- XZXYYPFLNTWIES-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]imidazo[2,1-a]isoquinoline Chemical compound FC(F)(F)C1=CC=CC(C=2N=C3C4=CC=CC=C4C=CN3C=2)=C1 XZXYYPFLNTWIES-UHFFFAOYSA-N 0.000 claims 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims 1
- GXDZIOGZVNWVIZ-UHFFFAOYSA-N 3-(5,6-dihydroimidazo[2,1-a]isoquinolin-2-yl)phenol Chemical compound OC1=CC=CC(C=2N=C3C4=CC=CC=C4CCN3C=2)=C1 GXDZIOGZVNWVIZ-UHFFFAOYSA-N 0.000 claims 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 claims 1
- VXPWSGTWXJOOII-UHFFFAOYSA-N 3-methyl-2-phenyl-5,6-dihydroimidazo[2,1-a]isoquinoline Chemical compound N1=C2C3=CC=CC=C3CCN2C(C)=C1C1=CC=CC=C1 VXPWSGTWXJOOII-UHFFFAOYSA-N 0.000 claims 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 1
- QLQIRVPZSJDVSO-UHFFFAOYSA-N 4-imidazo[2,1-a]isoquinolin-2-ylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 QLQIRVPZSJDVSO-UHFFFAOYSA-N 0.000 claims 1
- PUZBVDSTSGVOAG-UHFFFAOYSA-N 4-imidazo[2,1-a]isoquinolin-2-ylbenzonitrile Chemical compound C1=CC(C#N)=CC=C1C1=CN(C=CC=2C3=CC=CC=2)C3=N1 PUZBVDSTSGVOAG-UHFFFAOYSA-N 0.000 claims 1
- GMSPBBGIMCSHSZ-UHFFFAOYSA-N 5,6-dihydroimidazo[2,1-a]isoquinoline Chemical class C12=CC=CC=C2CCN2C1=NC=C2 GMSPBBGIMCSHSZ-UHFFFAOYSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- 239000005995 Aluminium silicate Substances 0.000 claims 1
- 241000416162 Astragalus gummifer Species 0.000 claims 1
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- 241000282693 Cercopithecidae Species 0.000 claims 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 240000007472 Leucaena leucocephala Species 0.000 claims 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 229920001615 Tragacanth Polymers 0.000 claims 1
- 240000000038 Ziziphus mauritiana Species 0.000 claims 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims 1
- OCCXMKHYCLMIKA-UHFFFAOYSA-N [Cl-].[NH+]1=CNC=2C=CC=3C=CN=CC=3C=21 Chemical compound [Cl-].[NH+]1=CNC=2C=CC=3C=CN=CC=3C=21 OCCXMKHYCLMIKA-UHFFFAOYSA-N 0.000 claims 1
- OBASDBHRXUCXKQ-UHFFFAOYSA-N [F].[Br] Chemical compound [F].[Br] OBASDBHRXUCXKQ-UHFFFAOYSA-N 0.000 claims 1
- 206010000210 abortion Diseases 0.000 claims 1
- 231100000176 abortion Toxicity 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 150000001242 acetic acid derivatives Chemical class 0.000 claims 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- 150000004781 alginic acids Chemical class 0.000 claims 1
- 239000012670 alkaline solution Substances 0.000 claims 1
- 125000005336 allyloxy group Chemical group 0.000 claims 1
- 235000012211 aluminium silicate Nutrition 0.000 claims 1
- 238000010171 animal model Methods 0.000 claims 1
- 238000013459 approach Methods 0.000 claims 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 claims 1
- 229960002903 benzyl benzoate Drugs 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- REHHBTUVMSHZNT-UHFFFAOYSA-N bromocyclohexatriene Chemical group BrC1=CC=C=C[CH]1 REHHBTUVMSHZNT-UHFFFAOYSA-N 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 235000010216 calcium carbonate Nutrition 0.000 claims 1
- 239000001506 calcium phosphate Substances 0.000 claims 1
- 229910000389 calcium phosphate Inorganic materials 0.000 claims 1
- 235000011010 calcium phosphates Nutrition 0.000 claims 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- ZHGASCUQXLPSDT-UHFFFAOYSA-N cyclohexanesulfonic acid Chemical class OS(=O)(=O)C1CCCCC1 ZHGASCUQXLPSDT-UHFFFAOYSA-N 0.000 claims 1
- 230000020335 dealkylation Effects 0.000 claims 1
- 238000006900 dealkylation reaction Methods 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000002270 dispersing agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 238000011049 filling Methods 0.000 claims 1
- 235000010855 food raising agent Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 150000003840 hydrochlorides Chemical class 0.000 claims 1
- 238000007327 hydrogenolysis reaction Methods 0.000 claims 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 1
- UVNXNSUKKOLFBM-UHFFFAOYSA-N imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=CSC2=NC=CN21 UVNXNSUKKOLFBM-UHFFFAOYSA-N 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical compound C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 claims 1
- 150000002537 isoquinolines Chemical class 0.000 claims 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 229940067606 lecithin Drugs 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 150000002688 maleic acid derivatives Chemical class 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 235000010755 mineral Nutrition 0.000 claims 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 239000010466 nut oil Substances 0.000 claims 1
- 235000019488 nut oil Nutrition 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 239000012044 organic layer Substances 0.000 claims 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims 1
- 235000021317 phosphate Nutrition 0.000 claims 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 231100000241 scar Toxicity 0.000 claims 1
- 230000037390 scarring Effects 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 235000015424 sodium Nutrition 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000001593 sorbitan monooleate Substances 0.000 claims 1
- 235000011069 sorbitan monooleate Nutrition 0.000 claims 1
- 229940035049 sorbitan monooleate Drugs 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 150000003890 succinate salts Chemical class 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 150000003892 tartrate salts Chemical class 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
- 231100000419 toxicity Toxicity 0.000 claims 1
- 230000001988 toxicity Effects 0.000 claims 1
- 239000000196 tragacanth Substances 0.000 claims 1
- 235000010487 tragacanth Nutrition 0.000 claims 1
- 229940116362 tragacanth Drugs 0.000 claims 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
Przedmiotem wynalazku jest sposób wytwarzania nowych pochodnych imidazoizochinoliny o wzorze 1,
w którym A oznacza grupe o wzorze -CH=CH- lub -CHa-CH2-, R oznacza nizsza grupe alkilowa, alkoksylowa,
alkenylpksylowa, alkinyloksylowa, grupe cyklopropyloksylowa, cyklobutyloksylowa, cyklopentyloksylowa,
cykloheksyloksylowa, hydroksylowa, benzyloksylowa, sulfamylowa, cyjanowa, trójfluorometylowa lub nitrowa,
albo atom fluoru, chloru, bromu lub jodu, Ri oznacza atom wodoru, fluoro, chloru lub bromu, nizsza grupe
alkoksylowa, albo razem z grupa R oznacza grupe metylenodwuoksy, a R2 oznacza atom wodoru lub nizsza
grupe alkilowa i ich nietoksycznych, dopuszczalnych farmaceutycznie soli addycyjnych z kwasami.
Otrzymane zwiazki dzialaja przeciwreprodukcyjnie, a zwlaszcza wykazuja znaczna aktywnosc przeciw
plodnosci po implantacji.
W opisie i
Claims (5)
1. Sposób wytwarzania nowych pochodnych imidazoizochinoliny o wzorze 1, w którym A oznacza grupe o wzorze -CH=CH- lutx -CH2 CH2-, R oznacza nizsza grupe alkilowa, alkoksylowa, alkenyloksylowa, alkinylo- ksylowa, grupe cyklopropyloksylowa, cyklobutyloksylowa, cyklopentyloksylowa, cykloheksyloksylowa, hydro¬ ksylowa, benzyloksylowa, sulfamylowa, cyjanowa, trójfluorometylowa lub nitrowa, albo atom fluoru, chloru, bromu lub jodu, Ri oznacza atom wodoru, fluoru, chloru lub bromu, nizsza grupe alkoksylowa albo razem z grupa R oznacza grupe metylenodwuoksy, a R2 oznacza atom wodoru lub nizsza grupe alkilowa i ich nietoksycznych, dopuszczalnych farmaceutycznie soli addycyjnych z kwasami, znamienny tym, ze 1-aminoizochinoline kontaktuje sie z halogenkiem fenacylu o wzorze 4, w którym symbol halo oznacza atom chloru lub bromu, a R, Rj i R2 maja wyzej podane znaczenie, przy czym otrzymuje sie chlorowcowodorek zwiazku o wzorze 1, w którym A oznacza grupe o wzorze -CH=CH-, a nastepnie otrzymany zwiazek przeksztalca100 077 7 sie dzialaniem wodnego roztworu zasady w odpowiednia wolna zasade i ewentualnie uwadarnia sie nasycony zwiazek o wzorze 1 w obecnosci katalizatora uwadarniania do zwiazku o wzorze 1, w którym A oznacza grupe o wzorze -CH2 -CH2 %
2. Sposób wedlug zastrz. 1, znamienny tym, ze kontaktuje sie reagenty w stosunku równomolo- wym.
3. Sposób wedlug zastrz. 1,znamienny tym, ze reagenty kontaktuje sie w obecnosci aprotycznego rozpuszczalnika organicznego, w temperaturze od temperatury pokojowej do temperatury wrzenia mieszaniny.
4. Sposób wedlug zastrz. 1,znamienny tym, ze reagenty kontaktuje sie w obecnosci aprotycznego rozpuszczalnika organicznego, takiego jak chlorowany nizszy weglowodór, dioksan, czterowodorofuran, benzen lub toluen.
5. Sposób wedlug zastrz. 1, znamienny tym, ze uwodornienie prowadzi sie w temperaturze 80—100°C, pod cisnieniem 8—15 atm w obecnosci Pd osadzonego na weglu. (X&c- R2 Wzór 1 R Wzór 4
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL18494675A PL100077B1 (pl) | 1975-11-22 | 1975-11-22 | Sposob wytwarzania nowych pochodnych imidazoizochinoliny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL18494675A PL100077B1 (pl) | 1975-11-22 | 1975-11-22 | Sposob wytwarzania nowych pochodnych imidazoizochinoliny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL100077B1 true PL100077B1 (pl) | 1978-08-31 |
Family
ID=19974376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18494675A PL100077B1 (pl) | 1975-11-22 | 1975-11-22 | Sposob wytwarzania nowych pochodnych imidazoizochinoliny |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL100077B1 (pl) |
-
1975
- 1975-11-22 PL PL18494675A patent/PL100077B1/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2158632C (en) | Catechol diether compounds as inhibitors of tnf release | |
| Dal Piaz et al. | 4, 5-Functionalized 6-phenyl-3 (2H)-pyridazinones: synthesis and evaluation of antinociceptive activity | |
| CA1068273A (en) | 2-phenyl-imidazo (2.1-a) isoquinoline compounds and their 5,6-dihydro derivatives | |
| US5322850A (en) | Antiallergic piperidine derivatives of benzimidazole | |
| SK92597A3 (en) | Heterocyclic condensed pyridines, method for producing the same, pharmaceutical compositions containing same and their use | |
| DK160550B (da) | Tetrahydroisoquinolin-2-ylderivater af carboxylsyrer som thromboxan-a2-antagonister, deres anvendelse i et medicinsk praeparat og farmaceutisk middel indeholdende dem | |
| US4472401A (en) | Pyrimido-quinoxalines having antiallergic properties | |
| EP0028381B1 (en) | Azepinoindoles, process for their production and pharmaceutical compositions containing them | |
| NO160995B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive bis -(4-aminofenyl)-sulfoner. | |
| HRP960009A2 (en) | 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones | |
| US4132709A (en) | [2]Benzopyrano[4,3-c]pyridine derivatives and process therefor | |
| EP0030351B1 (en) | Ergoline derivatives, their preparation and therapeutic composition containing them | |
| US4007276A (en) | Triazolo isoindole derivatives | |
| PL100077B1 (pl) | Sposob wytwarzania nowych pochodnych imidazoizochinoliny | |
| USRE30456E (en) | 2-Substituted phenyl-s-triazolo[5,1-a] isoquinoline compounds | |
| GB1569251A (en) | Pyridobenzodiazepines | |
| US4183932A (en) | Fused quinazolinones and preparation thereof | |
| US4075341A (en) | 2-Substituted phenyl-5-triazols [5,1-a] isoquinoline compounds | |
| US4228167A (en) | Diuretic and vasodilating tricyclic quinazolines | |
| US4275066A (en) | Antireproductive tricyclic ortho-fused nitrogen containing compounds | |
| EP0547224B1 (en) | 14-O-p-CHLOROBENZOYLACONINE AND ANALGESIC/ANTIINFLAMMATORY AGENT | |
| NZ206305A (en) | Benzazepine and benzodiazepine derivatives and pharmaceutical compositions | |
| US4313950A (en) | Antireproductive tricyclic ortho-fused nitrogen containing compounds | |
| CA1196342A (en) | Process for preparing benzylalcohol derivatives | |
| HU209393B (en) | Process for producing new, substituted oxazinoisoquinoline derivates |